NRP1 and cancer: The results are shown in Figure 1, where CD inhibits the NRP1 expressions in both the protein and the mRNA in dosage-dependent manners in the H1975 cells (Figure 1A,B), the BT549 cancer cells (Figure 1C,D), the PC3 prostate cancer cells (Figure 1E,F), and the 22RV1 prostate cancer cells (Figure 1G,H), respectively.